An oral medicine used for selected inflammatory diseases and cancer regimens. Schedules vary by indication; verify the exact prescription.
Profile scope: Methotrexate oral. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Nausea, mouth discomfort, fatigue, headache and hair thinning may occur.
Serious risks and warning signs
Major risks include marrow suppression, infection, liver or lung injury and embryo-fetal harm. Mistaking a prescribed weekly regimen for daily use has caused deaths. Fever, mouth ulcers, unusual bleeding, jaundice or new breathlessness needs urgent assessment.
A question for your healthcare team
Is my prescribed schedule weekly or another cancer-specific schedule, and what blood, kidney, liver, folate and pregnancy precautions apply?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
- NIH / MedlinePlus: full medicine information
- FDA: methotrexate fatal scheduling-error warning and other precautions
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.